TABLE 3.

The median percentage of change and p-value of Wilcoxon signed-rank test for each endocannabinoid. Asterisk (*) stands for statistically significant values.

		BAT (−)		BAT (+)
		60′vs. 0′	120′vs. 0′	60′vs. 0′	120′vs. 0′
AEA	p-value	0.02*	0.08	0.0001*	0.004*
	change [%]	−39.3	−15.1	−59.1	−32.9
EPEA	p-value	0.008*	0.55	0.0007*	0.008*
	change [%]	−28.0	−8.3	−32.0	−22.8
OEA	p-value	0.02*	0.38	0.002*	0.01*
	change [%]	−28.6	−13.3	−35.1	−24.8
PEA	p-value	0.06	0.31	0.008*	0.005*
	change [%]	−22.3	−15.9	−39.7	−29.9
SEA	p-value	0.06	0.25	0.03*	0.02*
	change [%]	−21.8	−10.3	−21.7	−32.3
2-AG	p-value	0.84	0.55	0.61	0.71
	change [%]	2.3	12.0	−16.0	0.9
DEA	p-value	0.25	0.95	0.03*	0.17
	change [%]	−13.0	−2.5	−29.9	−15.8
GP-AEA	p-value	0.02*	0.06	0.81	0.07
	change [%]	32.1	55.1	8.4	10.6
GP-EPEA	p-value	0.46	0.04*	0.82	0.07
	change [%]	16.0	10.9	0.1	15.3
GP-OEA	p-value	0.38	1	0.93	1
	change [%]	52.6	−6.4	2.9	−6.4
GP-PEA	p-value	0.20	0.46	0.58	0.75
	change [%]	49.4	11.4	−15.1	−4.3